<DOC>
	<DOC>NCT02975219</DOC>
	<brief_summary>Incomplete resection of endometriosis lesions often results in recurrence of symptoms and the need for repeated surgery, with considerable associated morbidity. The aim of this pilot project is to determine the feasibility of fluorescence imaging to improve the treatment of endometriosis in the future.</brief_summary>
	<brief_title>Feasibility Study of Using Molecular Fluorescence Guided Surgery in Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>1. Females aged â‰¥ 18 years 2. Scheduled for surgery for the treatment of endometriosis 3. WHO performance score of 02 4. Written informed consent For female subjects who are of childbearing potential, are premenopausal with intact reproductive organs or are less than 2 years postmenopausal: 5. A negative serum pregnancy test prior to receiving the tracer 6. Willing to ensure that she or her partner uses effective contraception during the trial and for 6 months thereafter. 1. Medical or psychiatric conditions that compromise the patient's ability to give informed consent 2. Pregnancy 3. History of infusion reactions to Bevacizumab or other monoclonal antibody therapies 4. Significant renal, cardiac, or pulmonary disease (ASA IIIIV)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>